J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report and a short review of the literature
María Chaparro,María Trapero-Marugán,Mercedes Guijarro,Consuelo López,Ricardo Moreno-Otero,Javier P. Gisbert +5 more
TL;DR: A case of a primary sclerosing cholangitis in a young male with a newly diagnosed ulcerative colitis presenting with colonic dysplasia is reported.
Journal ArticleDOI
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
Francisco Mesonero,Jesús Castro-Poceiro,José Manuel Benítez,Blau Camps,Marisa Iborra,A López-García,Paola Torres,Maria Esteve,Joan Tosca,Federico Bertoletti,Pedro Almela,Xavier Calvet,Isabel Vera,Luis Bujanda,Fernando Gomollón,Cristina Rodríguez,Beatriz Antolín,David Busquets,Alejandro Hernández,Montserrat Rivero,David Monfort i Miquel,Andrés Castaño-García,Javier P. Gisbert,Eugeni Domènech,Antonio López-Sanromán +24 more
TL;DR: In this paper, the effectiveness of methotrexate monotherapy in Crohn's disease patients after previous failure to anti-tumour necrosis factor (anti-TNFα) drugs was evaluated.
Journal ArticleDOI
Anticuerpos anticitoplasma de los neutrófilos en el diagnóstico de la colitis ulcerosa y la enfermedad de Crohn
TL;DR: PANCA sensitivity for a diagnosis of UC in patients with inflammatory bowel disease is also very low, yet the specificity is very high, yet indicating the need to standardize the methodology.
Journal ArticleDOI
W1274 Efficacy and Safety of Infliximab Rescue Therapy After Cyclosporine Failure in Patients With Steroid-Refractory Ulcerative Colitis: A Multicenter Study
María Chaparro,P. Burgueño,Eva Iglesias Flores,Julián Panés,Fernando Muñoz,Pilar Nos,Juan L. Mendoza,Carlos Jimenez,Luísa Castro,Xavier Calvet,Manuel Barreiro,Silvia Gómez Senent,Montserrat Andreu,Míriam Mañosa,María Gómez-García,Fernando Gomollón,Joaquín Hinojosa,Olga P Nyssen,Javier P. Gisbert +18 more
Journal ArticleDOI
Efficacy and safety of vedolizumab in the treatment of ulcerative colitis
TL;DR: This review presents the most relevant clinical outcomes of vedolizumab in the treatment of patients with ulcerative colitis.